CA35954B4047 - Common Stock
FSD PHARMA INC-CLASS B
NASDAQ:HUGE (8/14/2024, 8:21:03 PM)
After market: 0.0916 +0 (+1.89%)0.0899
-0.01 (-10.1%)
FSD Pharma, Inc. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. The firm operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.
FSD PHARMA INC-CLASS B
55 University Ave. , Suite 1003
TORONTO ONTARIO M5X 1A4
P: 14168548884
CEO: Raza Bokhari
Employees: 10
Website: https://www.fsdpharma.com/
HUGE stock results show that FSD Pharma missed analyst estimates for earnings per share the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips FSD Pharma (NASDAQ:HUGE) just reported results for the second quarter of 2024.F...
It's time to dive into the biggest pre-market stock movers for Tuesday as we check out all of the hottest news moving shares this morning.
It's time to dive into the biggest pre-market stock movers for Monday morning with all of the latest news affecting shares today!
FSD Pharma stock is up on Friday as HUGe ivnestors react to an update on its investment in Celly Nutrition and a new product launch.
Here you can normally see the latest stock twits on HUGE, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: